 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter D - Drugs for Human Use |
|
|
Part 341 - Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for over-the-Counter Human Use |
Part 341 - Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for over-the-Counter Human Use
| Subpart A - General Provisions |
| § 341.1 - Scope. |
| § 341.3 - Definitions. |
| Subpart B - Active Ingredients |
| § 341.12 - Antihistamine active ingredients. |
| § 341.14 - Antitussive active ingredients. |
| § 341.16 - Bronchodilator active ingredients. |
| § 341.18 - Expectorant active ingredient. |
| § 341.20 - Nasal decongestant active ingredients. |
| § 341.40 - Permitted combinations of active ingredients. |
| Subpart C - Labeling |
| § 341.70 - Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product). |
| § 341.72 - Labeling of antihistamine drug products. |
| § 341.74 - Labeling of antitussive drug products. |
| § 341.76 - Labeling of bronchodilator drug products. |
| § 341.78 - Labeling of expectorant drug products. |
| § 341.80 - Labeling of nasal decongestant drug products. |
| § 341.85 - Labeling of permitted combinations of active ingredients. |
| § 341.90 - Professional labeling. |